Research field (2)：
General surgery, pediatric surgery
, Tumor diagnostics and therapeutics
Research keywords (2)：
Medical Oncology
, Breast Cancer
Research theme for competitive and other funds (4)：
2023 - 2026 Elucidation of the action mechanism of ZAG on immune cells
2018 - 2020 Development of predictive marker using immune related cell in breast cancer
2015 - 2018 Development of breast cancer prognosis tool using the National Clinical Database-Breast Cancer Registry in Japan
2014 - 2016 Role of Androgen Receptor in Breast Cancer
Papers (120)：
Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi, et al. Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast cancer (Tokyo, Japan). 2024
Toshiki Kazama, Yui Nagafuji, Naoki Niikura, Takuho Okamura, Marc Van Cauteren, Makoto Obara, Susumu Takano, Natsuo Konta, Tomohiko Horie, Taro Takahara, et al. Utility of Echo-planar Imaging with Compressed Sensitivity Encoding (EPICS) in the Evaluation of Small Breast Cancers Using Diffusion-weighted Imaging with Background Suppression (DWIBS). Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine. 2024
Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura, Yeon Hee Park, Keun Seok Lee, Yee Soo Chae, Binghe Xu, Xiaojia Wang, Seock-Ah Im, et al. Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study. Breast cancer (Tokyo, Japan). 2024
T Takeshita, T Iwamoto, N Niikura, K Watanabe, Y Kikawa, K Kobayashi, N Iwakuma, T Okamura, H Tada, S Ozaki, et al. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing. ESMO open. 2024. 9. 4. 102385-102385
Toru Hanamura, Kozue Yokoyama, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, et al. Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment. Cancer immunology, immunotherapy : CII. 2024. 73. 3. 42-42
Mayako Terao, Naoki Niikura. Diagnosis of oligometastasis. Translational Cancer Research. 2020. 9. 8. 5032-5037
Hiroko Masuda, Tsutomu Iwasa, Toru Mukohara, Shinya Tokunaga, Koji Matsumoto, Naoki Niikura, Yasuaki Sagara, Yasuo Miyoshi, Akihiko Shimomura, Masato Takahashi, et al. Phase II study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with ER-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318B. CANCER RESEARCH. 2020. 80. 4
Hiroji Iwata, Toshinari Yamashita, Kenichi Inoue, Masato Takahashi, Norikazu Masuda, Teruo Yamauchi, Yutaka Yamamoto, Toshimi Takano, Naoki Niikura, Takahiro Nakayama, et al. Alpelisib (ALP) plus fulvestrant (FUL) in patients from Japan with advanced breast cancer: Subgroup analysis of SOLAR-1 trial. ANNALS OF ONCOLOGY. 2019. 30. 80-80
